Streetbeat News

Price Targets

HES

Susquehanna analyst Biju Perincheril maintains a positive outlook on Hess (NYSE:HES) and raises the price target from $187 to $197.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:51 pm

FANG

Susquehanna analyst Biju Perincheril maintains a positive outlook on Diamondback Energy (NASDAQ:FANG) and has raised the price target from $189 to $200.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:49 pm

MIRM

JMP Securities analyst Jonathan Wolleben has reiterated his 'Market Outperform' rating on Mirum Pharmaceuticals (NASDAQ:MIRM) and maintained a price target of $70.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:48 pm

GS

JMP Securities analyst Devin Ryan has reiterated a 'Market Outperform' rating on Goldman Sachs Gr (NYSE:GS) and maintained a price target of $440.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:46 pm

EOG

Susquehanna analyst Biju Perincheril maintains a positive outlook on EOG Resources (NYSE:EOG), but has lowered the price target from $165 to $164.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:44 pm

DVN

Susquehanna analyst Biju Perincheril maintains a positive outlook on Devon Energy (NYSE:DVN), but has lowered the price target from $72 to $62.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:38 pm

CTRA

Susquehanna analyst Biju Perincheril maintains a Neutral rating on Coterra Energy (NYSE:CTRA) and raises the price target from $28 to $31.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:37 pm

COP

Susquehanna analyst Biju Perincheril maintains a positive outlook on ConocoPhillips (NYSE:COP) but has lowered the price target from $153 to $152.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:35 pm

APA

Susquehanna analyst Biju Perincheril maintains a positive outlook on APA (NASDAQ:APA), but has lowered the price target from $54 to $53.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:34 pm

JNJ

Raymond James analyst Jayson Bedford has maintained an 'Outperform' rating on Johnson & Johnson (NYSE:JNJ), but lowered the price target from $179 to $172.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:31 pm